doi: 10.7326/0003-4819-157-9-201211060-00016.
Cardiovascular effects of diabetes drugs: emerging from the dark ages
- PMID: 23128866
- DOI: 10.7326/0003-4819-157-9-201211060-00016
Item in Clipboard
Cardiovascular effects of diabetes drugs: emerging from the dark ages
Ann Intern Med.
.
Free article
No abstract available
Comment in
-
Cardiovascular effects of diabetes drugs: making the dark ages brighter with Carolina.Ann Intern Med. 2013 Mar 19;158(6):499. doi: 10.7326/0003-4819-158-6-201303190-00017. Ann Intern Med. 2013. PMID: 23553039 No abstract available.
Similar articles
-
Controversy about the relationship between sulfonylurea use and cardiovascular events and mortality.J Diabetes Investig. 2016 Sep;7(5):674-6. doi: 10.1111/jdi.12494. Epub 2016 Mar 24. J Diabetes Investig. 2016. PMID: 27181105 Free PMC article.
-
Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study.Diabetes Obes Metab. 2010 Sep;12(9):757-65. doi: 10.1111/j.1463-1326.2010.01230.x. Diabetes Obes Metab. 2010. PMID: 20649627
-
Does mortality risk vary among sulfonylureas?Lancet Diabetes Endocrinol. 2015 Jan;3(1):6-7. doi: 10.1016/S2213-8587(14)70217-7. Epub 2014 Oct 22. Lancet Diabetes Endocrinol. 2015. PMID: 25466240 No abstract available.
-
Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part II--"The cons".Horm Metab Res. 1996 Sep;28(9):522-6. doi: 10.1055/s-2007-979845. Horm Metab Res. 1996. PMID: 8911991 Review.
-
[Measures to meet the side effects of sulfonylurea (SU) in the treatment of type 2 diabetes].Nihon Rinsho. 2002 Sep;60 Suppl 9:357-61. Nihon Rinsho. 2002. PMID: 12387018 Review. Japanese. No abstract available.
Cited by
-
Lessons From a Diabetes Clinic: Achieving Glycemic Goals and Clinical Use of Antidiabetic Agents in Patients With Type 2 Diabetes.Clin Diabetes. 2020 Jul;38(3):248-255. doi: 10.2337/cd19-0090. Clin Diabetes. 2020. PMID: 32699473 Free PMC article.
-
Treated glycosylated hemoglobin levels in individuals with diabetes mellitus vary little by health status: A retrospective cohort study.Medicine (Baltimore). 2016 Jun;95(24):e3894. doi: 10.1097/MD.0000000000003894. Medicine (Baltimore). 2016. PMID: 27310986 Free PMC article.
-
The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials.PLoS Med. 2016 Apr 12;13(4):e1001992. doi: 10.1371/journal.pmed.1001992. eCollection 2016 Apr. PLoS Med. 2016. PMID: 27071029 Free PMC article. Review.
-
Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies.BMC Cardiovasc Disord. 2016 Jan 15;16:14. doi: 10.1186/s12872-016-0187-5. BMC Cardiovasc Disord. 2016. PMID: 26769243 Free PMC article.
-
Frailty Attenuates the Impact of Metformin on Reducing Mortality in Older Adults with Type 2 Diabetes.J Endocrinol Diabetes Obes. 2014;2(2):1031. J Endocrinol Diabetes Obes. 2014. PMID: 25506599 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
